Philogen Stock Quote PHIL - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

20.90

Bid

20.60

Ask

21.00

Volume

2,006

20.70 Day's Range 21.00

15.50 52 Week Range 21.60

Market Cap

844.31M

Previous Close

21.00

Open

20.90

Last Trade

20.9

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

9,102

Shares Outstanding

40,397,605

Dividend Yield

PE Ratio

Earnings Per Share (EPS)

Revenue

Net Profit

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.philogen.com

Headquarters

Siena, Siena, Ita

Founded

1970

Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 21.00 €. Over the last year, Philogen shares have traded in a share price range of 15.50 € to 21.60 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 848.35 € million.

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1	0.480769230769	20.8	21	20.1	3717	20.79956414	DE
4	0.95	4.7619047619	19.95	21	19.95	5762	20.50752048	DE
12	2.95	16.43454039	17.95	21.6	17.6	9102	20.17833053	DE
26	3.6	20.8092485549	17.3	21.6	16.3	10481	18.70416638	DE
52	5	31.4465408805	15.9	21.6	15.5	11908	18.13232343	DE
156	6.9	49.2857142857	14	21.6	13	10161	15.9499592	DE
260	3.9	22.9411764706	17	21.6	12.6	12820	15.76274252	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	259.77k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.45M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M